Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul;38(3):571-586.
doi: 10.1016/j.ccc.2022.01.005. Epub 2022 Jan 10.

Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents

Allison M Blatz  1 , Adrienne G Randolph  2
Affiliations
Review

Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents

Allison M Blatz et al. Crit Care Clin. 2022 Jul.

Abstract

Severe complications related to COVID-19 occur infrequently in children and adolescents. these life-threatening complications are mainly acute respiratory failure from acute COVID-19 and multisystem inflammatory syndrome in children (MIS-C). MIS-C is a postinfectious complication occurring approximately 3 to 6 weeks mostly after an asymptomatic or mild SARS-CoV-2 infection. For both types of complications, supportive ICU care is often required. For MIS-C critical illness, immunomodulation is prescribed to reverse hyperinflammation and its cardiac and other sequelae.

Keywords: COVID-19; MIS-C; Multisystem inflammatory syndrome; Pediatrics.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Daily cases of Multisystem Inflammatory Syndrome in Children (MIS-C) in the U.S. reported to the Centers for Disease Control and Prevention (CDC) from the state public health departments in relation to reported pediatric cases of COVID-19.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Levin M. Childhood multisystem inflammatory syndrome — a new Challenge in the pandemic. NEJM. 2020;383(4):393–395. - PMC - PubMed
    1. Shekerdemian L.S., Mahmood N.R., Wolfe K.K., et al. Characteristics and outcomes of children with Coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care Units. JAMA Pediatr. 2020;2019:1–6. - PMC - PubMed
    1. Whitworth H., Sartain S., Kumar R., et al. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood. 2021;138(2):190–198. - PMC - PubMed
    1. LaRovere K.L., Riggs B.J., Poussaint T.Y., et al. Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome. JAMA Neurol. 2021;78(5):536–547. - PMC - PubMed
    1. Feldstein L.R., Tenforde M.W., Friedman K.G., et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA. 2021;325(11):1074–1087. - PMC - PubMed

Supplementary concepts